CA Patent

CA2699435A1 — Pharmaceutical compositions containing clostridium difficile toxoids a and b

Assigned to Sanofi Pasteur Biologics LLC · Expires 2009-03-19 · 17y expired

What this patent protects

This invention relates to compositions including Clostridium difficile toxins and/or toxoids and corresponding methods. The compositions of the invention include one or more excipients that increase stability and/or decrease aggregation of the toxins.

USPTO Abstract

This invention relates to compositions including Clostridium difficile toxins and/or toxoids and corresponding methods. The compositions of the invention include one or more excipients that increase stability and/or decrease aggregation of the toxins.

Drugs covered by this patent

Patent Metadata

Patent number
CA2699435A1
Jurisdiction
CA
Classification
—
Expires
2009-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Pasteur Biologics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.